These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32912229)

  • 21. TRIP6 accelerates the proliferation and invasion of cervical cancer by upregulating oncogenic YAP signaling.
    Yang F; Li L; Zhang J; Zhang J; Yang L
    Exp Cell Res; 2020 Nov; 396(1):112248. PubMed ID: 32853630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA LOXL1-AS1 promotes endometrial cancer progression by sponging miR-28-5p to upregulate RAP1B expression.
    Yang X; Xing G; Liu S; Li B; He Y; Wang F
    Biomed Pharmacother; 2020 May; 125():109839. PubMed ID: 32006897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CSRP2 suppresses colorectal cancer progression
    Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
    Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
    Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
    Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-544a Regulates Migration and Invasion in Colorectal Cancer Cells via Regulation of Homeobox A10.
    Sun S; Su C; Zhu Y; Li H; Liu N; Xu T; Sun C; Lv Y
    Dig Dis Sci; 2016 Sep; 61(9):2535-44. PubMed ID: 27165435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-140-3p inhibits colorectal cancer progression and its liver metastasis by targeting BCL9 and BCL2.
    Liu D; Chen C; Cui M; Zhang H
    Cancer Med; 2021 May; 10(10):3358-3372. PubMed ID: 33838016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
    Li GH; Yu JH; Yang B; Gong FC; Zhang KW
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development.
    Piao MY; Cao HL; He NN; Xu MQ; Dong WX; Wang WQ; Wang BM; Zhou B
    Scand J Gastroenterol; 2016; 51(5):572-82. PubMed ID: 26691157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The circular RNA circ-ERBIN promotes growth and metastasis of colorectal cancer by miR-125a-5p and miR-138-5p/4EBP-1 mediated cap-independent HIF-1α translation.
    Chen LY; Wang L; Ren YX; Pang Z; Liu Y; Sun XD; Tu J; Zhi Z; Qin Y; Sun LN; Li JM
    Mol Cancer; 2020 Nov; 19(1):164. PubMed ID: 33225938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells.
    Lu J; Zhang L; Zhou H; Du Z; Zhang G
    Oncol Rep; 2018 Aug; 40(2):887-894. PubMed ID: 29989653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High Expressions of CUL4A and TP53 in Colorectal Cancer Predict Poor Survival.
    Li C; Bu J; Liao Y; Zhang J; Han J; Zhang H; Xing H; Li Z; Wu H; Liang L; Wang M; Qin W; Yang T
    Cell Physiol Biochem; 2018; 51(6):2829-2842. PubMed ID: 30562757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CircTADA2A suppresses the progression of colorectal cancer via miR-374a-3p/KLF14 axis.
    Li Z; Yao H; Wang S; Li G; Gu X
    J Exp Clin Cancer Res; 2020 Aug; 39(1):160. PubMed ID: 32799891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypermethylated in cancer 1 (HIC1) suppresses bladder cancer progression by targeting yes-associated protein (YAP) pathway.
    Zhou X; Zhang P; Han H; Lei H; Zhang X
    J Cell Biochem; 2019 Apr; 120(4):6471-6481. PubMed ID: 30417565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling.
    Zheng X; Chen L; Zhou Y; Wang Q; Zheng Z; Xu B; Wu C; Zhou Q; Hu W; Wu C; Jiang J
    Mol Cancer; 2019 Mar; 18(1):47. PubMed ID: 30925892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myosin light chain 9 promotes the proliferation, invasion, migration and angiogenesis of colorectal cancer cells by binding to Yes-associated protein 1 and regulating Hippo signaling.
    Feng M; Dong N; Zhou X; Ma L; Xiang R
    Bioengineered; 2022 Jan; 13(1):96-106. PubMed ID: 34974798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling.
    Sharif GM; Schmidt MO; Yi C; Hu Z; Haddad BR; Glasgow E; Riegel AT; Wellstein A
    Oncogene; 2015 Nov; 34(48):5879-89. PubMed ID: 25772246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of miR-301a-3p promotes colorectal cancer cell proliferation and metastasis by targeting deleted in liver cancer-1 and runt-related transcription factor 3.
    Zhang L; Zhang Y; Zhu H; Sun X; Wang X; Wu P; Xu X
    J Cell Biochem; 2019 Apr; 120(4):6078-6089. PubMed ID: 30362160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.
    Li J; Chen Y; Guo X; Zhou L; Jia Z; Tang Y; Lin L; Liu W; Ren C
    Tumour Biol; 2016 Jul; 37(7):8765-73. PubMed ID: 26743779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.
    Gou H; Liang JQ; Zhang L; Chen H; Zhang Y; Li R; Wang X; Ji J; Tong JH; To KF; Sung JJY; Chan FKL; Fang JY; Yu J
    Cancer Res; 2019 Jul; 79(13):3332-3346. PubMed ID: 31018940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.